Pages
Products
Human TERT Lentivirus (CMV, Hygro)

Human TERT Lentivirus (CMV, Hygro)

Cat.No. :  LVIM007Z

Titer: ≥1*10^7 TU/mL / ≥1*10^8 TU/mL / ≥1*10^9 TU/mL Size: 100 ul/500 ul/1 mL

Storage:  -80℃ Shipping:  Frozen on dry ice

Inquire for Price

Lentivirus Particle Information

Quality Control

Cat. No. LVIM007Z
Description Lentivirus expressing untagged Human TERT under the control of CMV promoter, and hygromycin resistance marker for mammalian cell selection.
Target Gene TERT
Species Human
Application Human TERT (telomerase reverse transcriptase) lentivirus (CMV, Hygro) is a recombinant viral vector used in laboratory research to deliver the human TERT gene into cells. Applications of this lentivirus include: Cell immortalization: TERT plays a key role in extending telomeres and is therefore often used to extend the lifespan of primary cells, which usually have a limited ability to divide. Immortalized cells are very useful for long-term studies and experiments that require a continuous supply of the same cells. Cancer research: TERT is active in many cancer cells. The introduction of TERT into cells helps to understand the mechanisms of telomerase activity, the immortalization process, and how they promote cancer development and progression. Aging research: Because telomere shortening is associated with aging, studying the effects of TERT on the cellular aging process can provide insights into the mechanisms of aging and potential aging-related diseases. Drug screening and development: Immortalized cells with TERT can be used for high-throughput screening of compounds that affect telomerase activity, providing potential leads for cancer treatment and other telomere-related diseases. Stem cell research: Lentiviral delivery of TERT into stem cells can aid in studying the role of telomerase in stem cell maintenance, differentiation, and potential therapeutic uses.
Titer Varies lot by lot, for example, ≥1*10^7 TU/mL, ≥1*10^8 TU/mL, ≥1*10^9 TU/mL etc.
Size Varies lot by lot, for example, 100 ul, 500 ul, 1 mL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality lentivirus particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between lentivirus particle lots.
Mycoplasma Creative Biogene routinely tests for mycoplasma contamination using a mycoplasma detection kit. Cell lines are maintained for approximately 20 passages before being discarded and replaced with a new vial of early passage cells. Approximately 2 weeks after thawing, cell culture supernatants are tested for mycoplasma contamination. Creative Biogene ensures that lentiviral products are free of mycoplasma contamination.
Purity Creative Biogene evaluates the level of impurities, such as residual host cell DNA or proteins, in prepared lentiviral vectors to ensure they meet quality standards.
Sterility The lentiviral samples were inoculated into cell culture medium for about 5 days and the growth of bacteria and fungi was tested. Creative Biogene ensures that the lentiviral products are free of microbial contamination.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of lentivirus to deliver genetic material into target cells, and assess gene expression and functional activities.
Proviral Identity Confirmation All Creative Biogene lentiviral vectors are confirmed to have correctly integrated provirus using PCR. This test involves transducing cells with serial dilutions of the lentiviral vector, harvesting the cells a few days later, and isolating genomic DNA. This DNA is then used as a template to amplify a portion of the expected lentiviral insert.
Quick Inquiry

Background

Case Study

Publications

Q & A

Customer Reviews

The Human TERT (Telomerase Reverse Transcriptase) Lentivirus (CMV, Hygro) is an advanced genetic tool for studying and manipulating telomerase activity in mammalian cells. This lentivirus expresses untagged human TERT under the control of the cytomegalovirus (CMV) promoter, ensuring stable and high-level expression in a variety of cell types. In addition, it includes a hygromycin resistance marker to facilitate selection of successfully transduced cells by antibiotic resistance. Telomerase, of which TERT is the catalytic subunit, plays a crucial role in maintaining chromosomal integrity by lengthening telomeres, thereby preventing cellular senescence and promoting cell proliferation. The Human TERT Lentivirus is particularly useful for researchers aiming to study telomerase biology, cell immortality, the aging process, and related carcinogenic mechanisms. By utilizing this lentiviral system, scientists can overexpress TERT in target cells, thereby prolonging cell survival and allowing for extended periods of study, which is essential for detailed experiments.

Telomeres are DNA sequences that cap the ends of chromosomes and become shorter as cells divide. Telomerase maintains telomere length so that cells can continue to divide. Overcoming replicative senescence is an essential step in tumorigenesis, and reactivation of TERT through promoter mutations is a common mechanism. Approximately 75% of melanoma patients acquire TERT promoter mutations, but these are not sufficient to maintain telomeres, suggesting that additional mutations are required. Researchers have identified a cluster of variants in the ACD promoter, which encodes the shelterin component TPP1. Approximately 5% of cutaneous melanomas harbor ACD promoter variants that co-occur with TERT promoter mutations. The two most common somatic variants create or modify binding sites for the E-twenty-six (ETS) transcription factor, similar to mutations in the TERT promoter. These variants increase TPP1 expression and work together with TERT to synergistically lengthen telomeres. These findings suggest that TPP1 promoter variants work in concert with TERT activation to enhance telomere maintenance and immortalization in melanoma.

The study found that introduction of either the –75C>T or –108C>T variants significantly increased TPP1 expression (Figure 1A). The increase in TPP1 expression levels from the modified endogenous promoter was greater than that observed in the luciferase assay (Figure 1C), suggesting that other factors may contribute to TPP1 expression in melanoma. Telomeres in MEL624 and LOX cells are extremely long (>20 kb), precluding detection of length changes using Southern blot analysis. Therefore, fluorescence in situ hybridization (FISH) was used to detect modified telomeric sequences as a surrogate for telomerase activity in vivo (Figure 1B). The researchers used telomerase RNA encoding the variant telomeric repeat TTAGGT, which can be incorporated into telomeres and localized using a peptide nucleic acid fluorescent probe. Wild-type or genome-edited MEL624 or LOX cell lines with the most common promoter variants were co-transduced with lentivirus expressing the variant telomerase RNA and hTERT. Using FISH to determine the percentage of variant repeat sequences in telomeres, the study found that cells with modified TPP1 promoters incorporated more TTAGGT variant repeat sequences at telomeres (Figure 1C and D). These findings suggest that TPP1 promoter mutations cooperate with hTERT to increase telomere repeat addition in melanoma cells.

Figure 1. TPP1 promoter mutations increase expression of endogenous transcripts and occur simultaneously with TERT promoter mutations.Figure 1. TPP1 promoter mutations increase expression of endogenous transcripts and occur simultaneously with TERT promoter mutations. (Chun-On P, et al., 2022)

Customer Q&As
What kind of quality control does the product undergo?

A: The lentiviral expression construct was validated by full-length sequencing, restriction enzyme digestion and PCR-size validation using gene-specific and vector-specific primers. Product is confirmed free of bacteria, fungi and common Mycoplasma contamination.

Are the virus particles safe?

A: Yes.Creative Biogene lentiviral vectors include the most advanced bio-safety features developed for lentiviral vectors. The viral envelope(VSVG) and accessory proteins (gag-pol and rev) are separate from the expression lentivectors minimizing the potential for homologous recombination Additionally those packaaing components necessary for replication are excluded once the vira particles are packaged.Furthermore our lentivectors are derived from the third generation lentiviral system which includes a 3’-LTR self-inactivation(SIN) mechanism. These features ensure that the premade particles are not replicable(replication incompetent),meaning the self-replication of the original virus is impossible.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction